nodes	percent_of_prediction	percent_of_DWPC	metapath
Midodrine—Paraesthesia—Isotretinoin—peripheral nervous system neoplasm	0.00253	0.00253	CcSEcCtD
Midodrine—Paraesthesia—Tretinoin—peripheral nervous system neoplasm	0.00253	0.00253	CcSEcCtD
Midodrine—Urinary tract disorder—Cisplatin—peripheral nervous system neoplasm	0.00253	0.00253	CcSEcCtD
Midodrine—Dyspnoea—Tretinoin—peripheral nervous system neoplasm	0.00251	0.00251	CcSEcCtD
Midodrine—Dyspnoea—Isotretinoin—peripheral nervous system neoplasm	0.00251	0.00251	CcSEcCtD
Midodrine—Urethral disorder—Cisplatin—peripheral nervous system neoplasm	0.00251	0.00251	CcSEcCtD
Midodrine—Somnolence—Tretinoin—peripheral nervous system neoplasm	0.00251	0.00251	CcSEcCtD
Midodrine—Somnolence—Isotretinoin—peripheral nervous system neoplasm	0.00251	0.00251	CcSEcCtD
Midodrine—Dyspepsia—Topotecan—peripheral nervous system neoplasm	0.0025	0.0025	CcSEcCtD
Midodrine—Paraesthesia—Melphalan—peripheral nervous system neoplasm	0.0025	0.0025	CcSEcCtD
Midodrine—Dyspepsia—Isotretinoin—peripheral nervous system neoplasm	0.00248	0.00248	CcSEcCtD
Midodrine—Dyspepsia—Tretinoin—peripheral nervous system neoplasm	0.00248	0.00248	CcSEcCtD
Midodrine—Dyspnoea—Melphalan—peripheral nervous system neoplasm	0.00248	0.00248	CcSEcCtD
Midodrine—Hepatobiliary disease—Etoposide—peripheral nervous system neoplasm	0.00247	0.00247	CcSEcCtD
Midodrine—Gastrointestinal disorder—Topotecan—peripheral nervous system neoplasm	0.00245	0.00245	CcSEcCtD
Midodrine—Dyspepsia—Melphalan—peripheral nervous system neoplasm	0.00245	0.00245	CcSEcCtD
Midodrine—Back pain—Vincristine—peripheral nervous system neoplasm	0.00244	0.00244	CcSEcCtD
Midodrine—Gastrointestinal disorder—Tretinoin—peripheral nervous system neoplasm	0.00243	0.00243	CcSEcCtD
Midodrine—Gastrointestinal disorder—Isotretinoin—peripheral nervous system neoplasm	0.00243	0.00243	CcSEcCtD
Midodrine—Pain—Topotecan—peripheral nervous system neoplasm	0.00243	0.00243	CcSEcCtD
Midodrine—Pain—Tretinoin—peripheral nervous system neoplasm	0.00241	0.00241	CcSEcCtD
Midodrine—Pain—Isotretinoin—peripheral nervous system neoplasm	0.00241	0.00241	CcSEcCtD
Midodrine—Cramps of lower extremities—Epirubicin—peripheral nervous system neoplasm	0.00241	0.00241	CcSEcCtD
Midodrine—Agitation—Alitretinoin—peripheral nervous system neoplasm	0.00241	0.00241	CcSEcCtD
Midodrine—Gastrointestinal disorder—Melphalan—peripheral nervous system neoplasm	0.0024	0.0024	CcSEcCtD
Midodrine—Pain—Melphalan—peripheral nervous system neoplasm	0.00238	0.00238	CcSEcCtD
Midodrine—Flushing—Cisplatin—peripheral nervous system neoplasm	0.00238	0.00238	CcSEcCtD
Midodrine—Cardiac disorder—Cisplatin—peripheral nervous system neoplasm	0.00238	0.00238	CcSEcCtD
Midodrine—Feeling abnormal—Topotecan—peripheral nervous system neoplasm	0.00234	0.00234	CcSEcCtD
Midodrine—Gastrointestinal pain—Topotecan—peripheral nervous system neoplasm	0.00232	0.00232	CcSEcCtD
Midodrine—Feeling abnormal—Tretinoin—peripheral nervous system neoplasm	0.00232	0.00232	CcSEcCtD
Midodrine—Feeling abnormal—Isotretinoin—peripheral nervous system neoplasm	0.00232	0.00232	CcSEcCtD
Midodrine—Urinary tract disorder—Etoposide—peripheral nervous system neoplasm	0.00232	0.00232	CcSEcCtD
Midodrine—Agitation—Vincristine—peripheral nervous system neoplasm	0.00232	0.00232	CcSEcCtD
Midodrine—Gastrointestinal pain—Tretinoin—peripheral nervous system neoplasm	0.00231	0.00231	CcSEcCtD
Midodrine—Gastrointestinal pain—Isotretinoin—peripheral nervous system neoplasm	0.00231	0.00231	CcSEcCtD
Midodrine—Urethral disorder—Etoposide—peripheral nervous system neoplasm	0.0023	0.0023	CcSEcCtD
Midodrine—Hypertension—Alitretinoin—peripheral nervous system neoplasm	0.00226	0.00226	CcSEcCtD
Midodrine—Abdominal pain—Topotecan—peripheral nervous system neoplasm	0.00225	0.00225	CcSEcCtD
Midodrine—Abdominal pain—Tretinoin—peripheral nervous system neoplasm	0.00223	0.00223	CcSEcCtD
Midodrine—Abdominal pain—Isotretinoin—peripheral nervous system neoplasm	0.00223	0.00223	CcSEcCtD
Midodrine—Cramps of lower extremities—Doxorubicin—peripheral nervous system neoplasm	0.00223	0.00223	CcSEcCtD
Midodrine—Anxiety—Alitretinoin—peripheral nervous system neoplasm	0.00222	0.00222	CcSEcCtD
Midodrine—Erythema multiforme—Etoposide—peripheral nervous system neoplasm	0.00222	0.00222	CcSEcCtD
Midodrine—Unspecified disorder of skin and subcutaneous tissue—Alitretinoin—peripheral nervous system neoplasm	0.00221	0.00221	CcSEcCtD
Midodrine—Flatulence—Cisplatin—peripheral nervous system neoplasm	0.0022	0.0022	CcSEcCtD
Midodrine—Dry mouth—Alitretinoin—peripheral nervous system neoplasm	0.00218	0.00218	CcSEcCtD
Midodrine—Flushing—Etoposide—peripheral nervous system neoplasm	0.00218	0.00218	CcSEcCtD
Midodrine—Cardiac disorder—Etoposide—peripheral nervous system neoplasm	0.00218	0.00218	CcSEcCtD
Midodrine—Hypertension—Vincristine—peripheral nervous system neoplasm	0.00218	0.00218	CcSEcCtD
Midodrine—Hepatic function abnormal—Epirubicin—peripheral nervous system neoplasm	0.00218	0.00218	CcSEcCtD
Midodrine—Confusional state—Alitretinoin—peripheral nervous system neoplasm	0.00215	0.00215	CcSEcCtD
Midodrine—Muscle spasms—Cisplatin—peripheral nervous system neoplasm	0.00215	0.00215	CcSEcCtD
Midodrine—Angiopathy—Etoposide—peripheral nervous system neoplasm	0.00213	0.00213	CcSEcCtD
Midodrine—Chills—Etoposide—peripheral nervous system neoplasm	0.00211	0.00211	CcSEcCtD
Midodrine—Nervous system disorder—Alitretinoin—peripheral nervous system neoplasm	0.0021	0.0021	CcSEcCtD
Midodrine—Tachycardia—Alitretinoin—peripheral nervous system neoplasm	0.00209	0.00209	CcSEcCtD
Midodrine—Skin disorder—Alitretinoin—peripheral nervous system neoplasm	0.00208	0.00208	CcSEcCtD
Midodrine—Asthenia—Topotecan—peripheral nervous system neoplasm	0.00204	0.00204	CcSEcCtD
Midodrine—Asthenia—Tretinoin—peripheral nervous system neoplasm	0.00202	0.00202	CcSEcCtD
Midodrine—Asthenia—Isotretinoin—peripheral nervous system neoplasm	0.00202	0.00202	CcSEcCtD
Midodrine—Nervous system disorder—Vincristine—peripheral nervous system neoplasm	0.00202	0.00202	CcSEcCtD
Midodrine—Hepatic function abnormal—Doxorubicin—peripheral nervous system neoplasm	0.00201	0.00201	CcSEcCtD
Midodrine—Pruritus—Topotecan—peripheral nervous system neoplasm	0.00201	0.00201	CcSEcCtD
Midodrine—Asthenia—Melphalan—peripheral nervous system neoplasm	0.002	0.002	CcSEcCtD
Midodrine—Pruritus—Tretinoin—peripheral nervous system neoplasm	0.002	0.002	CcSEcCtD
Midodrine—Pruritus—Isotretinoin—peripheral nervous system neoplasm	0.002	0.002	CcSEcCtD
Midodrine—Back pain—Etoposide—peripheral nervous system neoplasm	0.00198	0.00198	CcSEcCtD
Midodrine—Pain—Dactinomycin—peripheral nervous system neoplasm	0.00197	0.00197	CcSEcCtD
Midodrine—Pruritus—Melphalan—peripheral nervous system neoplasm	0.00197	0.00197	CcSEcCtD
Midodrine—Muscle spasms—Etoposide—peripheral nervous system neoplasm	0.00197	0.00197	CcSEcCtD
Midodrine—Insomnia—Alitretinoin—peripheral nervous system neoplasm	0.00193	0.00193	CcSEcCtD
Midodrine—Paraesthesia—Alitretinoin—peripheral nervous system neoplasm	0.00192	0.00192	CcSEcCtD
Midodrine—Dyspnoea—Alitretinoin—peripheral nervous system neoplasm	0.00191	0.00191	CcSEcCtD
Midodrine—Somnolence—Alitretinoin—peripheral nervous system neoplasm	0.0019	0.0019	CcSEcCtD
Midodrine—Feeling abnormal—Dactinomycin—peripheral nervous system neoplasm	0.0019	0.0019	CcSEcCtD
Midodrine—Anxiety—Cisplatin—peripheral nervous system neoplasm	0.00189	0.00189	CcSEcCtD
Midodrine—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—peripheral nervous system neoplasm	0.00189	0.00189	CcSEcCtD
Midodrine—Gastrointestinal pain—Dactinomycin—peripheral nervous system neoplasm	0.00188	0.00188	CcSEcCtD
Midodrine—Dyspepsia—Alitretinoin—peripheral nervous system neoplasm	0.00188	0.00188	CcSEcCtD
Midodrine—Dizziness—Topotecan—peripheral nervous system neoplasm	0.00188	0.00188	CcSEcCtD
Midodrine—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.00186	0.00186	CcSEcCtD
Midodrine—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.00186	0.00186	CcSEcCtD
Midodrine—Insomnia—Vincristine—peripheral nervous system neoplasm	0.00186	0.00186	CcSEcCtD
Midodrine—Paraesthesia—Vincristine—peripheral nervous system neoplasm	0.00185	0.00185	CcSEcCtD
Midodrine—Gastrointestinal disorder—Alitretinoin—peripheral nervous system neoplasm	0.00185	0.00185	CcSEcCtD
Midodrine—Pain—Alitretinoin—peripheral nervous system neoplasm	0.00183	0.00183	CcSEcCtD
Midodrine—Abdominal pain—Dactinomycin—peripheral nervous system neoplasm	0.00182	0.00182	CcSEcCtD
Midodrine—Rash—Topotecan—peripheral nervous system neoplasm	0.00179	0.00179	CcSEcCtD
Midodrine—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.00179	0.00179	CcSEcCtD
Midodrine—Nervous system disorder—Cisplatin—peripheral nervous system neoplasm	0.00179	0.00179	CcSEcCtD
Midodrine—Headache—Topotecan—peripheral nervous system neoplasm	0.00178	0.00178	CcSEcCtD
Midodrine—Rash—Isotretinoin—peripheral nervous system neoplasm	0.00178	0.00178	CcSEcCtD
Midodrine—Rash—Tretinoin—peripheral nervous system neoplasm	0.00178	0.00178	CcSEcCtD
Midodrine—Gastrointestinal disorder—Vincristine—peripheral nervous system neoplasm	0.00178	0.00178	CcSEcCtD
Midodrine—Tachycardia—Cisplatin—peripheral nervous system neoplasm	0.00178	0.00178	CcSEcCtD
Midodrine—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.00178	0.00178	CcSEcCtD
Midodrine—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.00178	0.00178	CcSEcCtD
Midodrine—Skin disorder—Cisplatin—peripheral nervous system neoplasm	0.00177	0.00177	CcSEcCtD
Midodrine—Headache—Tretinoin—peripheral nervous system neoplasm	0.00177	0.00177	CcSEcCtD
Midodrine—Headache—Isotretinoin—peripheral nervous system neoplasm	0.00177	0.00177	CcSEcCtD
Midodrine—Hypertension—Etoposide—peripheral nervous system neoplasm	0.00176	0.00176	CcSEcCtD
Midodrine—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	0.00176	0.00176	CcSEcCtD
Midodrine—Pain—Vincristine—peripheral nervous system neoplasm	0.00176	0.00176	CcSEcCtD
Midodrine—Rash—Melphalan—peripheral nervous system neoplasm	0.00175	0.00175	CcSEcCtD
Midodrine—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.00175	0.00175	CcSEcCtD
Midodrine—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	0.00175	0.00175	CcSEcCtD
Midodrine—Dry skin—Epirubicin—peripheral nervous system neoplasm	0.00174	0.00174	CcSEcCtD
Midodrine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—peripheral nervous system neoplasm	0.00173	0.00173	CcSEcCtD
Midodrine—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.00169	0.00169	CcSEcCtD
Midodrine—Nausea—Topotecan—peripheral nervous system neoplasm	0.00169	0.00169	CcSEcCtD
Midodrine—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.00168	0.00168	CcSEcCtD
Midodrine—Confusional state—Etoposide—peripheral nervous system neoplasm	0.00168	0.00168	CcSEcCtD
Midodrine—Nausea—Tretinoin—peripheral nervous system neoplasm	0.00167	0.00167	CcSEcCtD
Midodrine—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.00167	0.00167	CcSEcCtD
Midodrine—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.00165	0.00165	CcSEcCtD
Midodrine—Nausea—Melphalan—peripheral nervous system neoplasm	0.00165	0.00165	CcSEcCtD
Midodrine—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	0.00164	0.00164	CcSEcCtD
Midodrine—Tachycardia—Etoposide—peripheral nervous system neoplasm	0.00163	0.00163	CcSEcCtD
Midodrine—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.00163	0.00163	CcSEcCtD
Midodrine—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	0.00162	0.00162	CcSEcCtD
Midodrine—Skin disorder—Etoposide—peripheral nervous system neoplasm	0.00162	0.00162	CcSEcCtD
Midodrine—Dry skin—Doxorubicin—peripheral nervous system neoplasm	0.00161	0.00161	CcSEcCtD
Midodrine—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.00157	0.00157	CcSEcCtD
Midodrine—Pain—Cisplatin—peripheral nervous system neoplasm	0.00156	0.00156	CcSEcCtD
Midodrine—Dysuria—Epirubicin—peripheral nervous system neoplasm	0.00154	0.00154	CcSEcCtD
Midodrine—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.00153	0.00153	CcSEcCtD
Midodrine—Pollakiuria—Epirubicin—peripheral nervous system neoplasm	0.00152	0.00152	CcSEcCtD
Midodrine—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.00151	0.00151	CcSEcCtD
Midodrine—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.0015	0.0015	CcSEcCtD
Midodrine—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.0015	0.0015	CcSEcCtD
Midodrine—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.00149	0.00149	CcSEcCtD
Midodrine—Somnolence—Etoposide—peripheral nervous system neoplasm	0.00148	0.00148	CcSEcCtD
Midodrine—Asthenia—Vincristine—peripheral nervous system neoplasm	0.00148	0.00148	CcSEcCtD
Midodrine—Stevens-Johnson syndrome—Epirubicin—peripheral nervous system neoplasm	0.00145	0.00145	CcSEcCtD
Midodrine—Rash—Dactinomycin—peripheral nervous system neoplasm	0.00145	0.00145	CcSEcCtD
Midodrine—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.00144	0.00144	CcSEcCtD
Midodrine—Stomatitis—Epirubicin—peripheral nervous system neoplasm	0.00143	0.00143	CcSEcCtD
Midodrine—Pain—Etoposide—peripheral nervous system neoplasm	0.00143	0.00143	CcSEcCtD
Midodrine—Dysuria—Doxorubicin—peripheral nervous system neoplasm	0.00142	0.00142	CcSEcCtD
Midodrine—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.00141	0.00141	CcSEcCtD
Midodrine—Pollakiuria—Doxorubicin—peripheral nervous system neoplasm	0.00141	0.00141	CcSEcCtD
Midodrine—Hepatobiliary disease—Epirubicin—peripheral nervous system neoplasm	0.00139	0.00139	CcSEcCtD
Midodrine—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.00137	0.00137	CcSEcCtD
Midodrine—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.00137	0.00137	CcSEcCtD
Midodrine—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.00136	0.00136	CcSEcCtD
Midodrine—Dizziness—Vincristine—peripheral nervous system neoplasm	0.00136	0.00136	CcSEcCtD
Midodrine—Rash—Alitretinoin—peripheral nervous system neoplasm	0.00135	0.00135	CcSEcCtD
Midodrine—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.00135	0.00135	CcSEcCtD
Midodrine—Stevens-Johnson syndrome—Doxorubicin—peripheral nervous system neoplasm	0.00134	0.00134	CcSEcCtD
Midodrine—Bradycardia—Epirubicin—peripheral nervous system neoplasm	0.00134	0.00134	CcSEcCtD
Midodrine—Headache—Alitretinoin—peripheral nervous system neoplasm	0.00134	0.00134	CcSEcCtD
Midodrine—Stomatitis—Doxorubicin—peripheral nervous system neoplasm	0.00132	0.00132	CcSEcCtD
Midodrine—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.00132	0.00132	CcSEcCtD
Midodrine—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.00131	0.00131	CcSEcCtD
Midodrine—Urinary tract disorder—Epirubicin—peripheral nervous system neoplasm	0.0013	0.0013	CcSEcCtD
Midodrine—Rash—Vincristine—peripheral nervous system neoplasm	0.0013	0.0013	CcSEcCtD
Midodrine—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.0013	0.0013	CcSEcCtD
Midodrine—Urethral disorder—Epirubicin—peripheral nervous system neoplasm	0.00129	0.00129	CcSEcCtD
Midodrine—Headache—Vincristine—peripheral nervous system neoplasm	0.00129	0.00129	CcSEcCtD
Midodrine—Hepatobiliary disease—Doxorubicin—peripheral nervous system neoplasm	0.00128	0.00128	CcSEcCtD
Midodrine—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.00127	0.00127	CcSEcCtD
Midodrine—Erythema multiforme—Epirubicin—peripheral nervous system neoplasm	0.00124	0.00124	CcSEcCtD
Midodrine—Bradycardia—Doxorubicin—peripheral nervous system neoplasm	0.00124	0.00124	CcSEcCtD
Midodrine—Nausea—Vincristine—peripheral nervous system neoplasm	0.00122	0.00122	CcSEcCtD
Midodrine—Flushing—Epirubicin—peripheral nervous system neoplasm	0.00122	0.00122	CcSEcCtD
Midodrine—Cardiac disorder—Epirubicin—peripheral nervous system neoplasm	0.00122	0.00122	CcSEcCtD
Midodrine—Urinary tract disorder—Doxorubicin—peripheral nervous system neoplasm	0.0012	0.0012	CcSEcCtD
Midodrine—Asthenia—Etoposide—peripheral nervous system neoplasm	0.0012	0.0012	CcSEcCtD
Midodrine—Angiopathy—Epirubicin—peripheral nervous system neoplasm	0.00119	0.00119	CcSEcCtD
Midodrine—Urethral disorder—Doxorubicin—peripheral nervous system neoplasm	0.00119	0.00119	CcSEcCtD
Midodrine—Chills—Epirubicin—peripheral nervous system neoplasm	0.00118	0.00118	CcSEcCtD
Midodrine—Pruritus—Etoposide—peripheral nervous system neoplasm	0.00118	0.00118	CcSEcCtD
Midodrine—Mental disorder—Epirubicin—peripheral nervous system neoplasm	0.00115	0.00115	CcSEcCtD
Midodrine—Erythema multiforme—Doxorubicin—peripheral nervous system neoplasm	0.00115	0.00115	CcSEcCtD
Midodrine—Rash—Cisplatin—peripheral nervous system neoplasm	0.00115	0.00115	CcSEcCtD
Midodrine—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.00115	0.00115	CcSEcCtD
Midodrine—Flushing—Doxorubicin—peripheral nervous system neoplasm	0.00113	0.00113	CcSEcCtD
Midodrine—Cardiac disorder—Doxorubicin—peripheral nervous system neoplasm	0.00113	0.00113	CcSEcCtD
Midodrine—Flatulence—Epirubicin—peripheral nervous system neoplasm	0.00113	0.00113	CcSEcCtD
Midodrine—Tension—Epirubicin—peripheral nervous system neoplasm	0.00112	0.00112	CcSEcCtD
Midodrine—Nervousness—Epirubicin—peripheral nervous system neoplasm	0.00111	0.00111	CcSEcCtD
Midodrine—Back pain—Epirubicin—peripheral nervous system neoplasm	0.00111	0.00111	CcSEcCtD
Midodrine—Angiopathy—Doxorubicin—peripheral nervous system neoplasm	0.0011	0.0011	CcSEcCtD
Midodrine—Dizziness—Etoposide—peripheral nervous system neoplasm	0.0011	0.0011	CcSEcCtD
Midodrine—Muscle spasms—Epirubicin—peripheral nervous system neoplasm	0.0011	0.0011	CcSEcCtD
Midodrine—Chills—Doxorubicin—peripheral nervous system neoplasm	0.00109	0.00109	CcSEcCtD
Midodrine—Nausea—Cisplatin—peripheral nervous system neoplasm	0.00108	0.00108	CcSEcCtD
Midodrine—Mental disorder—Doxorubicin—peripheral nervous system neoplasm	0.00107	0.00107	CcSEcCtD
Midodrine—Agitation—Epirubicin—peripheral nervous system neoplasm	0.00105	0.00105	CcSEcCtD
Midodrine—Rash—Etoposide—peripheral nervous system neoplasm	0.00105	0.00105	CcSEcCtD
Midodrine—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.00105	0.00105	CcSEcCtD
Midodrine—Headache—Etoposide—peripheral nervous system neoplasm	0.00105	0.00105	CcSEcCtD
Midodrine—Flatulence—Doxorubicin—peripheral nervous system neoplasm	0.00104	0.00104	CcSEcCtD
Midodrine—Tension—Doxorubicin—peripheral nervous system neoplasm	0.00104	0.00104	CcSEcCtD
Midodrine—Nervousness—Doxorubicin—peripheral nervous system neoplasm	0.00103	0.00103	CcSEcCtD
Midodrine—Back pain—Doxorubicin—peripheral nervous system neoplasm	0.00103	0.00103	CcSEcCtD
Midodrine—Muscle spasms—Doxorubicin—peripheral nervous system neoplasm	0.00102	0.00102	CcSEcCtD
Midodrine—Nausea—Etoposide—peripheral nervous system neoplasm	0.000991	0.000991	CcSEcCtD
Midodrine—Hypertension—Epirubicin—peripheral nervous system neoplasm	0.000989	0.000989	CcSEcCtD
Midodrine—Agitation—Doxorubicin—peripheral nervous system neoplasm	0.000974	0.000974	CcSEcCtD
Midodrine—Anxiety—Epirubicin—peripheral nervous system neoplasm	0.000972	0.000972	CcSEcCtD
Midodrine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	0.000969	0.000969	CcSEcCtD
Midodrine—Dry mouth—Epirubicin—peripheral nervous system neoplasm	0.000954	0.000954	CcSEcCtD
Midodrine—Confusional state—Epirubicin—peripheral nervous system neoplasm	0.000943	0.000943	CcSEcCtD
Midodrine—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	0.000917	0.000917	CcSEcCtD
Midodrine—Hypertension—Doxorubicin—peripheral nervous system neoplasm	0.000915	0.000915	CcSEcCtD
Midodrine—Tachycardia—Epirubicin—peripheral nervous system neoplasm	0.000913	0.000913	CcSEcCtD
Midodrine—Skin disorder—Epirubicin—peripheral nervous system neoplasm	0.000908	0.000908	CcSEcCtD
Midodrine—Anxiety—Doxorubicin—peripheral nervous system neoplasm	0.000899	0.000899	CcSEcCtD
Midodrine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	0.000896	0.000896	CcSEcCtD
Midodrine—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	0.000883	0.000883	CcSEcCtD
Midodrine—Confusional state—Doxorubicin—peripheral nervous system neoplasm	0.000872	0.000872	CcSEcCtD
Midodrine—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000849	0.000849	CcSEcCtD
Midodrine—Insomnia—Epirubicin—peripheral nervous system neoplasm	0.000846	0.000846	CcSEcCtD
Midodrine—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	0.000844	0.000844	CcSEcCtD
Midodrine—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	0.00084	0.00084	CcSEcCtD
Midodrine—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	0.00084	0.00084	CcSEcCtD
Midodrine—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	0.000834	0.000834	CcSEcCtD
Midodrine—Somnolence—Epirubicin—peripheral nervous system neoplasm	0.000831	0.000831	CcSEcCtD
Midodrine—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	0.000823	0.000823	CcSEcCtD
Midodrine—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000807	0.000807	CcSEcCtD
Midodrine—Pain—Epirubicin—peripheral nervous system neoplasm	0.0008	0.0008	CcSEcCtD
Midodrine—Insomnia—Doxorubicin—peripheral nervous system neoplasm	0.000783	0.000783	CcSEcCtD
Midodrine—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000777	0.000777	CcSEcCtD
Midodrine—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	0.000771	0.000771	CcSEcCtD
Midodrine—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	0.000771	0.000771	CcSEcCtD
Midodrine—Somnolence—Doxorubicin—peripheral nervous system neoplasm	0.000769	0.000769	CcSEcCtD
Midodrine—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	0.000765	0.000765	CcSEcCtD
Midodrine—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	0.000762	0.000762	CcSEcCtD
Midodrine—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000747	0.000747	CcSEcCtD
Midodrine—Pain—Doxorubicin—peripheral nervous system neoplasm	0.00074	0.00074	CcSEcCtD
Midodrine—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	0.000739	0.000739	CcSEcCtD
Midodrine—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000713	0.000713	CcSEcCtD
Midodrine—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	0.000708	0.000708	CcSEcCtD
Midodrine—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	0.000684	0.000684	CcSEcCtD
Midodrine—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.000671	0.000671	CcSEcCtD
Midodrine—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.000662	0.000662	CcSEcCtD
Midodrine—Asthenia—Doxorubicin—peripheral nervous system neoplasm	0.000621	0.000621	CcSEcCtD
Midodrine—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.000618	0.000618	CcSEcCtD
Midodrine—Pruritus—Doxorubicin—peripheral nervous system neoplasm	0.000612	0.000612	CcSEcCtD
Midodrine—Rash—Epirubicin—peripheral nervous system neoplasm	0.00059	0.00059	CcSEcCtD
Midodrine—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.000589	0.000589	CcSEcCtD
Midodrine—Headache—Epirubicin—peripheral nervous system neoplasm	0.000586	0.000586	CcSEcCtD
Midodrine—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.000572	0.000572	CcSEcCtD
Midodrine—Nausea—Epirubicin—peripheral nervous system neoplasm	0.000555	0.000555	CcSEcCtD
Midodrine—Rash—Doxorubicin—peripheral nervous system neoplasm	0.000546	0.000546	CcSEcCtD
Midodrine—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.000545	0.000545	CcSEcCtD
Midodrine—Headache—Doxorubicin—peripheral nervous system neoplasm	0.000542	0.000542	CcSEcCtD
Midodrine—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.000514	0.000514	CcSEcCtD
